- Home
- CRBP vs RFM Comparison
CRBP vs RFM Comparison
Compare CRBP & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- RFM
- Stock Information
- Founded
- CRBP 2009
- RFM 2020
- Country
- CRBP United States
- RFM United States
- Employees
- CRBP N/A
- RFM N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- RFM Finance/Investors Services
- Sector
- CRBP Health Care
- RFM Finance
- Exchange
- CRBP Nasdaq
- RFM Nasdaq
- Market Cap
- CRBP 73.4M
- RFM 85.8M
- IPO Year
- CRBP N/A
- RFM N/A
- Fundamental
- Price
- CRBP $7.34
- RFM $14.09
- Analyst Decision
- CRBP Strong Buy
- RFM
- Analyst Count
- CRBP 10
- RFM 0
- Target Price
- CRBP $53.56
- RFM N/A
- AVG Volume (30 Days)
- CRBP 114.6K
- RFM 20.7K
- Earning Date
- CRBP 05-06-2025
- RFM 01-01-0001
- Dividend Yield
- CRBP N/A
- RFM 9.74%
- EPS Growth
- CRBP N/A
- RFM N/A
- EPS
- CRBP N/A
- RFM N/A
- Revenue
- CRBP N/A
- RFM N/A
- Revenue This Year
- CRBP N/A
- RFM N/A
- Revenue Next Year
- CRBP $150.00
- RFM N/A
- P/E Ratio
- CRBP N/A
- RFM N/A
- Revenue Growth
- CRBP N/A
- RFM N/A
- 52 Week Low
- CRBP $4.64
- RFM $12.89
- 52 Week High
- CRBP $61.90
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- CRBP 52.51
- RFM 41.94
- Support Level
- CRBP $7.05
- RFM $14.01
- Resistance Level
- CRBP $7.62
- RFM $14.18
- Average True Range (ATR)
- CRBP 0.49
- RFM 0.11
- MACD
- CRBP -0.02
- RFM -0.02
- Stochastic Oscillator
- CRBP 42.65
- RFM 15.69
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.